Publications in VIVO

Co-author Network

Co-investigator Network

Elena Myasoedova, MD, PhD

Dr.

Positions

Associate Professor, Mayo Clinic

Location

Rochester, MN 55902

USA

Clinical Disciplines

Publications
Research
Other
View All

Selected Publications

article
1. Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity. Scientific reports. 13:5360. 2023
2. Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis. Arthritis care & research. 75:76-84. 2023
3. Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study. The Journal of rheumatology. 50:48-55. 2023
4. Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions. The Journal of rheumatology. jrheum.221170. 2023
5. Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population‐Based Cohort of Patients With Rheumatoid Arthritis. Arthritis care & research. 75:210-219. 2023
6. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries. 2022
7. Association between work physical activity, dietary factors, and risk of rheumatoid arthritis. Seminars in arthritis and rheumatism. 57:152100. 2022
8. Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs). Therapeutic advances in musculoskeletal disease. 14:1759720X2211059. 2022
9. Body mass index trend and variability in rheumatoid arthritis.. Clinical rheumatology. 41:349-355. 2022
10. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data. Arthritis research & therapy. 24:162. 2022
11. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis. 2022
12. Dr. Gunderson et al reply. The Journal of rheumatology. 49:964.2-964. 2022
13. Dr. Kodishala et al reply. The Journal of rheumatology. jrheum.221021. 2022
14. Future challenges in rheumatology – is telemedicine the solution?. Therapeutic advances in musculoskeletal disease. 14:1759720X2210816. 2022
15. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort.. Arthritis care & research. 74:2042-2049. 2022
16. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging. Journal of Alzheimer's disease : JAD. 89:943-954. 2022
17. The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study.. Seminars in arthritis and rheumatism. 52:151941. 2022
18. Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.. Arthritis care & research. 74:879-888. 2022
19. Defeating the Hydra of Excess Cardiovascular Disease Risk in Rheumatoid Arthritis - How Close Are We to Completing the Task?. The Journal of rheumatology. 48:629-632. 2021
20. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit. 2021
21. Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study.. The Journal of rheumatology. 48:1641-1647. 2021
22. Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis.. Arthritis care & research. 73:180-187. 2021
23. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. 2021
24. Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis-A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed. 2021
25. Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study.. The Journal of rheumatology. 48:1379-1387. 2021
26. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study.. The Journal of rheumatology. 48:1648-1654. 2021
27. New era for outcomes and management of rheumatoid arthritis: Facing the individualized treatment challenge.. Joint bone spine. 88:105066. 2021
28. Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study.. Arthritis Research and Therapy. 23:244. 2021
29. Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study.. Seminars in arthritis and rheumatism. 51:853-857. 2021
30. Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis.. The Journal of rheumatology. 48:1508-1511. 2021
31. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.. Seminars in arthritis and rheumatism. 50:261-265. 2020
32. Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis.. Arthritis and Rheumatology. 72:733-749. 2020
33. Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.. Autoimmunity reviews. 19:102688. 2020
34. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis.. Seminars in arthritis and rheumatism. 50:1348-1356. 2020
35. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population.. Seminars in arthritis and rheumatism. 50:25-29. 2020
36. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014.. Annals of the rheumatic diseases. 79:440-444. 2020
37. Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease.. Journal of the American College of Cardiology. 76:2226-2234. 2020
38. Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort.. Rheumatology and therapy. 7:979-991. 2020
39. Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis.. Mayo Clinic proceedings. 94:2488-2498. 2019
40. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity.. Mayo Clinic proceedings. 94:2241-2248. 2019
41. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.. Clinical rheumatology. 38:3025-3032. 2019
42. Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population.. Mayo Clinic proceedings. 94:1035-1039. 2019
43. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?. The Journal of rheumatology. 44:732-739. 2017
44. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.. Rheumatology (Oxford, England). 56:2154-2161. 2017
45. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk.. Current opinion in rheumatology. 29:277-284. 2017
46. Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014.. Clinical rheumatology. 35:2427-36. 2016
47. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.. Annals of the rheumatic diseases. 75:560-5. 2016
48. Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study.. The Journal of rheumatology. 41:1638-44. 2014
49. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study.. Arthritis and rheumatism. 65:1713-8. 2013
50. Cardiovascular risk in psoriasis: a population-based analysis with assessment of the framingham risk score.. Scientifica. 2013:371569. 2013
51. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study.. Arthritis care & research. 65:1592-9. 2013
52. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study.. Arthritis care & research. 65:854-61. 2013
53. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study.. The Journal of rheumatology. 40:1082-8. 2013
54. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study.. The Journal of rheumatology. 39:1355-62. 2012
55. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.. The Journal of rheumatology. 38:983-9. 2011
56. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.. The Journal of rheumatology. 38:29-35. 2011
57. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease.. Annals of the rheumatic diseases. 70:482-7. 2011
58. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota.. Gastroenterology research and practice. 2011:745829. 2011
59. Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis.. Arthritis care & research. 63:39-52. 2011
60. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.. Rheumatology (Oxford, England). 50:6-15. 2011
61. The influence of rheumatoid arthritis disease characteristics on heart failure.. The Journal of rheumatology. 38:1601-6. 2011
62. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.. Arthritis and rheumatism. 63:633-9. 2011
63. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.. Arthritis care & research. 63:729-34. 2011
64. Cardiovascular disease in rheumatoid arthritis: a step forward.. Current opinion in rheumatology. 22:342-7. 2010
65. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.. Current rheumatology reports. 12:379-85. 2010
66. Increased prevalence of diastolic dysfunction in rheumatoid arthritis.. Annals of the rheumatic diseases. 69:1665-70. 2010
67. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.. Arthritis and rheumatism. 62:1576-82. 2010
68. Total cholesterol and LDL levels decrease before rheumatoid arthritis.. Annals of the rheumatic diseases. 69:1310-4. 2010
document
1. Response to: 'Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population' by Matthijssen et al.. Annals of the rheumatic diseases. e70. 2022
2. To the editor: Response to Kao et al.. Seminars in arthritis and rheumatism. 151990. 2022
3. Reply.. Arthritis and Rheumatology. 2164-2165. 2020